Esor-40
Esomeprazole gastro-resistant tablets I.P. 40mg for superior acid suppression and healing of GI ulcers.
Scientific Profile
Therapeutic composition and clinical applications
Therapeutic Profile
Esor-40 contains Esomeprazole 40mg gastro-resistant tablets I.P., a potent proton pump inhibitor that heals 92%-94% of patients with erosive esophagitis. Esor-40 suppresses gastric acidity more effectively and in more individuals than pantoprazole 40mg daily and rabeprazole 20mg daily, ensuring superior healing rates and improved symptom relief with fewer therapy-resistant patients. It is significantly more effective at controlling gastric acidity above pH 4 for more than 16 hours.
Category
Gastroenterology
Indications
- check_circleDuodenal Ulcer
- check_circleDrug Induced Ulcer
- check_circleReflux Esophagitis
- check_circleZollinger Ellison Syndrome
Ready to partner with Amphar?
Get detailed product specifications, bulk pricing, and distribution opportunities.
Amphar Health Care